Since its inception in 1972, BAPI has been playing a key role in developing the pharma sector in the country to promote access to affordable drugs.

  Closely working with the industry and regulatory authorities, the association promotes understanding of good manufacturing practices (GMP), and rightful implementation to ensure quality of the medicines.

  It actively negotiates with the government and other relevant authorities to protect the interests of the industry eventually for the larger benefit of the common people.

  BAPI organizes awareness programs, workshops and seminars on evolving regulatory and compliance issues, counterfeit and adulterated drugs, role of generics in healthcare, technological advances in the industry, global pharma landscape and various other topics.

  It also organizes roadshows and exhibitions and participates in international events and exchange programs to promote our pharma industry to the global marketplace.

  Bangladesh is emerging as a generic drug hub in the region which is now ideally positioned to meet the contract manufacturing needs of global MNCs through its competitive generic drug skills. BAPI has been playing a leading role in taking Bangladesh pharma industry to the world, for the greater benefit of the people across all the continents, by promoting access to generics which are affordable.